Anadrol Related Published Studies
Well-designed clinical trials related to Anadrol (Oxymetholone)
The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients. [2010.12]
Oxymetholone ameliorates insulin sensitivity in maintenance hemodialysis patients: a randomized controlled trial. [2009.04]
Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women. [2003.05]
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. [2003.03.28]
Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. [1996.01]
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. [1992.05.15]
Well-designed clinical trials possibly related to Anadrol (Oxymetholone)
Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. [2003.01]
Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. [1993.01]
Other research related to Anadrol (Oxymetholone)
The efficacy of oxymetholone in combination with erythropoietin on hematologic
parameters and muscle mass in CAPD patients. [2010]
Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells. [2006.07]
Intracerebroventricular self-administration of commonly abused anabolic-androgenic steroids in male hamsters (Mesocricetus auratus): nandrolone, drostanolone, oxymetholone, and stanozolol. [2005.06]
Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid. [2001.06]
Cerebral venous thrombosis associated with tentorial subdural hematoma during oxymetholone therapy. [2001.03.15]
Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. [2000.11]
Effect of oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation. [1999.01.01]
Oxymetholone therapy in patients with familial antithrombin III deficiency. [1988.12.22]
Perturbations of the human menstrual cycle by oxymetholone. [1975.01.01]
Other possibly related research studies
Clonal monosomy 7 in a megakaryoblastic leukemia developed on the basis of Fanconi anemia. [2005.10]
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. [2005.05]
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. [2004.11]
Testosterone replacement for hypogonadism: clinical findings and best practices. [2003.12]
Therapies with potential toxicity of neuro-ophthalmic interest. [2003.12]
Littoral cell angioma of the spleen in a patient with severe aplastic anaemia. [2003.11]
Inherited aplastic anaemia. [2003]
Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia. [1997.04]
Aplastic anemia complicating systemic lupus erythematosus--report of a case and review of the literature. [2002.11]
Ampullary carcinoma developing after androgenic steroid therapy for aplastic anemia: Report of a case. [2001.04]
Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. [2000]
Transponder-induced sarcoma in the heterozygous p53+/- mouse. [1999.09]
Poststeroid balance disorder--a case report in a body builder. [1999.08]
Refractory anemia with excess of blasts: increased survival when treated with cyclophosphamide, methotrexate and 6-mercaptopurine. [1999.04]
A case of aplastic anaemia in pregnancy. [1999.02]
Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. [1999.02]
A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin. [1998.06]
Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience. [1997.05]
Treatment results of 23 cases of severe aplastic anemia with lymphocytapheresis. [1997.03]
[Allopurinol induced pancytopenia in a patient with myeloproliferative disorder] [1997.01]
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature. [1996.06]
Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids. [1995.03]
Rupture of the triceps tendon associated with steroid injections. [1993.05]
Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. [1992.11]
Aplastic anaemia: a review of cases at the University College Hospital, Ibadan, Nigeria. [1992.09]
Acquired amegakaryocytic thrombocytopaenia in a child. [1992.06]
A child with xeroderma pigmentosum and bone marrow failure. [1992.04]
A clinico-haematologic profile of paroxysmal nocturnal haemoglobinuria. [1991.10]
Acquired aplastic anaemia: still a serious disease. [1991.07]
Hepatocellular carcinoma and squamous cell carcinoma in a patient with Fanconi's anemia. [1991.07]
[Prednisolone, 1 alpha hydroxyvitamin D3 and androgens in the management in patients with refractory anemias] [1988.04]
Transfusion haemosiderosis inspite of regular use of desferrioxamine: case report. [2004.06]
Case of complete recovery of pancytopenia after treatment of hypopituitarism. [2004.05]
Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. [2003.06]
Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. [2002.09]
Danazol treatment of idiopathic myelofibrosis with severe anemia. [2000.06]
Use of growth hormone and other anabolic agents in AIDS wasting. [1999.11]
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia. [1993.09]
[Improvement of anemia by recombinant human erythropoietin in paroxysmal nocturnal hemoglobinuria] [1993.09]
[Aplastic anemia successfully treated with erythropoietin and rhG-CSF] [1992.09]
A familial case of hereditary angioneurotic edema in Japan. [1992.03]
[Bone marrow transplantation in Fanconi's anemia. Results in 5 patients] [1990.12]
[Successful treatment of a case of hepatitis-associated severe aplastic anemia by anti-lymphocyte globulin (ALG)] [1990.11]
[Aplastic anemia which terminated in hypoplastic leukemia 10 years after diagnosis] [1990.09]
Effect of extended use of single anabolic steroids on urinary steroid excretion and metabolism. [1989.04.07]
Zygomycosis in aplastic anaemia: response to a combined regimen of amphotericin B and antilymphocyte globulin. [1988.04]
[Results of treatment for severe acquired aplastic anemia in children] [1995.03]
[Multiple discriminant analysis for prognosis of refractory anemia] [1991.08]
Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. [1994.07.16]
Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. [2008.01]
Cost analysis of iron-related complications in a single institute. [2009.03]
Clinical course of non-severe aplastic anemia in adults. [2010.06]
Spontaneous liver rupture in a patient with peliosis hepatis: a case report. [2009.11.21]
Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-alpha when the anti-erythropoietin antibody titer declines spontaneously. [2010.11]
Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids. [2010.06]
Androgens for the anaemia of chronic kidney disease in adults. [2014]
|